Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET BP OFF-MED
NCT03503773Phase 2Completed
- Sponsor
- Ablative Solutions
- Start
- Sep 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ethanol in hypertension (HTN), sponsored by Ablative Solutions. Started Sep 2018; status: completed.
02
Drugs
ethanol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03503773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503773.